Immune Dysfunction in Multiple Sclerosis: Modern Considerations in Treatment and Management

Released: January 11, 2021 Expires: January 11, 2022 Program Description This activity provides an overview of the role of the innate and adaptive immune systems in the development and progression of multiple sclerosis (MS), while exploring the therapeutic implications of immune dysfunction. MS immunotherapies are reviewed, with a focus on their mechanisms of action and …

Evolving Treatment Paradigms in Multiple Sclerosis: Essential Updates for Neurology Teams

*Canadian HCPs only* Tuesday, Mar 16, 2021 2:00 – 3:00 PM Eastern (11:00 AM Pacific) Intended Audience: Neurology teams (physicians, PAs, NPs, nurses, and pharmacists) providing care for patients with MS Advances in therapeutics have delivered a multitude of treatment options for multiple sclerosis (MS), including multiple S1P-based disease-modifying therapies (DMTs). Tune into this webcast …

Initiating or Switching Therapy in Multiple Sclerosis: New Evidence and Expert Insights

*US and Canadian HCPs* Release Date: November 30, 2020 Expiration Date: November 30, 2021 Intended Audience: Physicians and their teams providing care for patients with MS (PAs, NPs, nurses, pharmacists) Accompanying this activity are resources to provide evidence-based guidance on necessary laboratory evaluations needed before initiating or switching DMTs, as well as a guide for …

IJMSC: Identifying Barriers to and Facilitators of Health Service Access Encountered by Individuals with Multiple Sclerosis

Release Date: February 1, 2021 Valid for Credit Through: February 1, 2022 Identifying Barriers to and Facilitators of Health Service Access Encountered by Individuals with Multiple Sclerosis Chantel D. Mayo, MSc*; Negar Farzam-kia, BSc*; Setareh Ghahari, PhD, OT Reg (Ont) Target Audience: The target audience for this activity is physicians, physician assistants, nursing professionals, mental …

Examining the Evidence for Early Initiation of Disease-Modifying Therapy

RELEASE DATE: December 21, 2020 VALID FOR CREDIT THROUGH: December 21, 2021 Provided by The Consortium of Multiple Sclerosis Centers and International Organization of Multiple Sclerosis Nurses and Spire Learning. This activity is supported by an educational grant from Genentech, a member of the Roche Group. PRIMARY AUDIENCE: This multidisciplinary educational initiative is targeted to …

Exploring the Use of Diagnostic Tools to Improve Early Detection of MS

RELEASE DATE: December 21, 2020 VALID FOR CREDIT THROUGH: December 21, 2021 Provided by The Consortium of Multiple Sclerosis Centers and International Organization of Multiple Sclerosis Nurses and Spire Learning. This activity is supported by an educational grant from Genentech, a member of the Roche Group. PRIMARY AUDIENCE: This multidisciplinary educational initiative is targeted to …

Clinical Insights on When and How to Switch DMT in Patients With a Suboptimal Treatment Response

RELEASE DATE: December 21, 2020 VALID FOR CREDIT THROUGH: December 21, 2021 Provided by The Consortium of Multiple Sclerosis Centers and International Organization of Multiple Sclerosis Nurses and Spire Learning. This activity is supported by an educational grant from Genentech, a member of the Roche Group. PRIMARY AUDIENCE: This multidisciplinary educational initiative is targeted to …

The New Era of Neuromyelitis Optica Spectrum Disorder: Advances in Diagnosis and Treatment – Jan. 14

Thursday, January 14, 2021 06:30 – 7:30 pm EST Learning Objectives Define symptoms of NMOSD and common diseases that mimic NMOSD Summarize consensus diagnostic criteria for NMOSD Review diagnostic testing methods for NMOSD Employ team-based approaches to the early and accurate diagnosis of NMOSD Review novel treatment options for NMOSD Apply evidence-based approaches to personalizing …

The New Era of Neuromyelitis Optica Spectrum Disorder: Advances in Diagnosis and Treatment – Jan. 19

Thursday, January 19, 2021 07:00 – 08:00 pm EST Learning Objectives Define symptoms of NMOSD and common diseases that mimic NMOSD Summarize consensus diagnostic criteria for NMOSD Review diagnostic testing methods for NMOSD Employ team-based approaches to the early and accurate diagnosis of NMOSD Review novel treatment options for NMOSD Apply evidence-based approaches to personalizing …